A cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...

Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...

After the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...

A decision to make a switch should be made only if it is clear that the vaccine failed to work or is only offering sub-par protection again...

Taiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-rule...

Taiwan has millions of vaccine doses on order, from AstraZeneca Plc and Moderna Inc, but has received only slightly more than 700,000 to da...

Ugur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...

The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...

Pfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021. BioNTech cited its new facility...

The delays in rolling out the home-grown vaccine have caused consternation in Germany, where some regions had to halt vaccinations within d...

In an email to The Associated Press, the European Medicines Agency said that BioNTech, which developed its vaccine together with Pfizer, ha...

The first phase of the China-based manufacturing facility will have production capacity of 200 million doses, Caixin said, citing people fa...

The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for speeded-up, conditional a...

Pfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, ...

The drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is counting on to end a pandemic that has...

BioNTech said in a statement that in a next step, it will begin increasing the dose of BNT162 in a trial involving about 200 participants a...

The drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, th...